A Study of LY03003 in Patients With Early-stage Parkinson's Disease

Summary

This study is to characterize the pharmacokinetics and to evaluate the safety as well as tolerability of LY03003 following multiple escalating intramuscular injections

Timeline

Start

2013-11-22

Primary completion

2014-02-26

Completion

2015-06-11

Drugs

Indications